Morton Plant Hospital

BayCare Earns National Recognitions for Patient Experience with 12 Press Ganey Awards

Retrieved on: 
Monday, January 8, 2024

These national awards are part of Press Ganey's annual ranking of the top hospitals and health systems throughout the U.S. Press Ganey annually surveys patients of more than 41,000 health care facilities, asking them questions about overall safety, quality and experience of care.

Key Points: 
  • These national awards are part of Press Ganey's annual ranking of the top hospitals and health systems throughout the U.S. Press Ganey annually surveys patients of more than 41,000 health care facilities, asking them questions about overall safety, quality and experience of care.
  • BayCare won three of Press Ganey's "Pinnacle of Excellence – Patient Experience" awards, which are given to locations that have achieved the top 5% in delivering patient experience over a three-year period.
  • Additionally, BayCare won nine of Press Ganey's "Guardian of Excellence – Patient Experience" awards, which are given to locations that have achieved the top 5% for patient experience over a one-year time frame.
  • BayCare's ambulatory services won nine of the 12 Press Ganey awards, including seven Guardian of Excellence Awards.

Mevion Selected to Equip BayCare’s Proton Therapy Center in Tampa

Retrieved on: 
Friday, November 3, 2023

Mevion Medical Systems, the leading provider of compact single-room proton therapy systems, is pleased to announce it has been selected by BayCare to equip the St. Joseph’s Hospital Cancer Institute in Tampa with a MEVION S250-FIT Proton Therapy System™*.

Key Points: 
  • Mevion Medical Systems, the leading provider of compact single-room proton therapy systems, is pleased to announce it has been selected by BayCare to equip the St. Joseph’s Hospital Cancer Institute in Tampa with a MEVION S250-FIT Proton Therapy System™*.
  • “BayCare is bringing an advanced proton radiation therapy center to Tampa so patients in our community don’t have to drive to Orlando or beyond to get this level of high-quality care.”
    The MEVION S250-FIT Proton Therapy System is thoughtfully designed to expedite proton therapy project timelines with a compact footprint, reduced construction requirements, and accelerated installation process.
  • “We are dedicated to advancing proton therapy technology and access, and I look forward to making a meaningful difference to patients and families across West Central Florida.”
    *The MEVION S250-FIT Proton Therapy System, FLASH therapy, online adaptive therapy, and ARC therapy are not yet available for clinical use.
  • Dedicated to advancing the design and accessibility of proton therapy worldwide, Mevion pioneered the single-room platform and continues to further the science and application of proton therapy.

St. Joseph's Hospital to Open First Proton Radiation Therapy Center in Tampa Bay Area

Retrieved on: 
Friday, November 3, 2023

TAMPA, Fla., Nov. 3, 2023 /PRNewswire/ -- Construction of the first proton therapy center to open in the Tampa Bay area is set to begin at St. Joseph's Hospital Cancer Institute, bringing technologically advanced treatment closer to home for local cancer patients.

Key Points: 
  • TAMPA, Fla., Nov. 3, 2023 /PRNewswire/ -- Construction of the first proton therapy center to open in the Tampa Bay area is set to begin at St. Joseph's Hospital Cancer Institute , bringing technologically advanced treatment closer to home for local cancer patients.
  • "BayCare is bringing the first proton radiation therapy center to Tampa so patients in our community don't have to drive to Orlando or beyond to get this level of high-quality care."
  • Woods Radiation Therapy Center and proton therapy treatment is expected to be available by fall 2025.
  • Woods Radiation Therapy Center at St. Joseph's Hospital treats more than 900 patients each year using a variety of radiation therapy treatments and state-of-the-art equipment.

Praxis Medical Announces FDA Clearance of the EndoCore EBUS-TBNA Biopsy Device

Retrieved on: 
Tuesday, October 17, 2023

Praxis Medical announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance of the EndoCore EBUS-TBNA fine needle biopsy device.

Key Points: 
  • Praxis Medical announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance of the EndoCore EBUS-TBNA fine needle biopsy device.
  • This procedure is performed by inserting a long, flexible fine needle through a bronchoscope for biopsy and pathological analysis.
  • The device is powered by a motor that rotates the needle during biopsy to facilitate cellular harvesting.
  • “We expect the EndoCore device will collect larger samples of tissue with higher cellularity which could translate to higher success rates for ancillary testing.

Morton Plant First in Florida to Participate in Trial to Expand TAVR to Aortic Regurgitation Patients

Retrieved on: 
Wednesday, February 1, 2023

The team has been using the minimally invasive TAVR procedure to treat patients with aortic stenosis since 2012, when Morton Plant became the first hospital in the Tampa Bay area to offer TAVR.

Key Points: 
  • The team has been using the minimally invasive TAVR procedure to treat patients with aortic stenosis since 2012, when Morton Plant became the first hospital in the Tampa Bay area to offer TAVR.
  • The Align trial is the first use of a TAVR valve designed to treat primary aortic regurgitation in a native valve by the Morton Plant team.
  • Aortic stenosis is the narrowing of the aortic valve, which restricts blood flow to the heart.
  • In patients with aortic regurgitation or aortic insufficiency, blood pumped from the left ventricle leaks back into the heart because the aortic valve doesn't close properly.

CLEARWATER MARINE AQUARIUM LAUNCHES NEW AUDIO TOUR, SPONSORED BY BAYCARE

Retrieved on: 
Tuesday, December 27, 2022

CLEARWATER, Fla., Dec. 27, 2022 /PRNewswire/ -- Clearwater Marine Aquarium announces the launch of a new audio tour for guests to immerse themselves in CMA's marine life conservation efforts and learn more about the rescued marine animals in their care.

Key Points: 
  • CLEARWATER, Fla., Dec. 27, 2022 /PRNewswire/ -- Clearwater Marine Aquarium announces the launch of a new audio tour for guests to immerse themselves in CMA's marine life conservation efforts and learn more about the rescued marine animals in their care.
  • Guests also have the option to select a children's or adult version, sponsored by BayCare, while a limited supply of braille devices and headsets for individuals with hearing impairments are also available.
  • "We're proud to support the Clearwater Marine Aquarium and its efforts to preserve our precious environment," said Lou Galdieri, Co-Chief Operating Officer of BayCare, a not-for-profit health system that includes Morton Plant Hospital, which is located on the Clearwater waterfront.
  • As a nod to their history, Clearwater Marine Science Center founder Mary McCormack leads the kids tour as "Eco-Ranger Mary."

BayCare Promotes Leaders to Expanded Roles

Retrieved on: 
Friday, December 9, 2022

CLEARWATER, Fla., Dec. 9, 2022 /PRNewswire/ -- BayCare Health System today announced the promotion of three senior executives to assume more responsibility within the not-for-profit health care organization.

Key Points: 
  • CLEARWATER, Fla., Dec. 9, 2022 /PRNewswire/ -- BayCare Health System today announced the promotion of three senior executives to assume more responsibility within the not-for-profit health care organization.
  • Two veteran operations leaders, Lou Galdieri and Kimberly Guy, have been named Co-Chief Operating Officers for the system.
  • "My goal in promoting these established leaders is to elevate their influence as we work together to make BayCare the best place to receive care, the best place to provide care and the best place to work."
  • BayCare's diverse network of ambulatory services includes laboratories, imaging, surgical centers, BayCare Urgent Care locations, wellness centers and one of Florida's largest home care agencies, BayCare HomeCare.

DataLink Augments Senior Executive Team to Serve Company Growth, Appoints Chief Growth and Chief Technology Officers

Retrieved on: 
Tuesday, September 27, 2022

DataLink Software (DataLink), a leading provider of data-driven solutions driving higher quality and cost-effective value-based care, today announces the appointment of industry veterans Sandip Patel as chief growth officer and Reddy Shivampet as chief technology officer.

Key Points: 
  • DataLink Software (DataLink), a leading provider of data-driven solutions driving higher quality and cost-effective value-based care, today announces the appointment of industry veterans Sandip Patel as chief growth officer and Reddy Shivampet as chief technology officer.
  • Their expertise will help us pursue our mission to empower better health while simplifying the delivery of value-based care.
  • Patel has worked in several executive roles, including with American Managed Care, Orion Communities, and The Well Care Group.
  • As new members of the DataLink team, these professionals look forward to contributing to the anticipated growth of the company.

BayCare Receives Recognition for its Minimally Invasive Transcatheter Valve Procedures

Retrieved on: 
Thursday, June 23, 2022

The certification recognizes each program's expertise and commitment to excellence in treating patients receiving transcatheter valve repair and replacement procedures.

Key Points: 
  • The certification recognizes each program's expertise and commitment to excellence in treating patients receiving transcatheter valve repair and replacement procedures.
  • This causes the heart to work harder to push blood through the calcified aortic valve.
  • Before Transcatheter Aortic Valve Replacement (TAVR), the primary solution for patients suffering from aortic stenosis was open heart surgery, which was not an option for many people.
  • Participation in established national clinical databases is required for hospitals interested in achieving Transcatheter Valve Certification.

LivaNova Announces First Patient Implanted in OSPREY Clinical Study for Patients Coping with Obstructive Sleep Apnea

Retrieved on: 
Thursday, February 24, 2022

LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, today announced the first patient implanted in the investigational device exemption (IDE) clinical study, Treating Obstructive Sleep Apnea using Targeted Hypoglossal Neurostimulation ( OSPREY ).

Key Points: 
  • LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, today announced the first patient implanted in the investigational device exemption (IDE) clinical study, Treating Obstructive Sleep Apnea using Targeted Hypoglossal Neurostimulation ( OSPREY ).
  • The first OSPREY patient was implanted by Dr. Mitchell Miller at BayCares Morton Plant Hospital in Clearwater, Florida.
  • Throughout the study, independent statisticians will conduct interim data analyses to determine predictive probability of success for OSPREY.
  • Clinical consequences and economic costs of untreated obstructive sleep apnea syndrome World Journal of Otorhinolaryngology-Head and Neck Surgery 2015; 1: 17-27.